In humans, mutation in MYH9 results in hematopoietic defects such as macrothrombocytopenia, NMHC IIA aggregation in neutrophil granulocytes, which makes it important to study the role of MYH9 in hematopoiesis. Here, MYH9 is linked to Macrothrombocytopenia.